A 48-year-old womanwith Cushing's syndrome due to bilateral adrenocortical adenomas is reported. The patient presented with a typical Cushingoid appearance. The serum cortisol level was elevated with loss of the diurnal rhythm and the plasma adrenocorticotropic hormone (ACTH) level was undetectable. Dynamic testing showed no suppression of urinary 17-OHCSby high-dose dexamethasone and no stimulation by metyrapone. An abdominal computed tomography (CT) scan showed bilateral adrenal tumors. Bilateral adrenalectomy was performed. The right adrenal gland contained a tumor that was encapsulated and consisted mainly of compact cells. The surrounding cortex was atrophic. The left adrenal gland contained an encapsulated tumor composedpredominantly of clear cells. There were numerous small adrenocortical nodules in the surrounding cortex. Immunohistochemical analysis of steroidogenic enzymes (P450scc, 3P-HSD, P450c21, P450cl7 and P450cll) was performed. Immunoreactivity of all the enzymes was intense in the compact cells of the right adrenocortical adenoma,while the adjacent non-neoplastic cortex was negative for the enzymes. In the left adrenal tumor, the immunoreactivity of 3(3-HSD was intense, while that of P450cl7 was weak. In the adrenocortical nodules, 3(3-HSD activity was sporadically observed. G protein genes encoding Gs a and Gi2 were examined for activating mutations at codons 201 and 227 (Gs a) and codons 179 and 205 (Gi2 a) in the bilateral adrenal tumors, but no mutations were found. The bilateral adenomas of this patient showed marked differences in microscopic and immunohistochemical studies, suggesting that the capacity of steroidogenesis differs between the right and left tumors. (Internal Medicine 36: 804-809, 1997) 
Introduction
EndogenousCushing's syndrome can be divided into two general types: adrenocorticotropic hormone(ACTH)-dependent and ACTH-independent. The majority of ACTH-independent Cushing's syndrome is due to a unilateral adrenocortical lesion. ACTH-independent Cushing's syndrome is occasionally caused by bilateral adrenocortical lesions. These include primary pigmented nodular adrenocortical disease (PPNAD), ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH) and bilateral adrenocortical tumors. The endocrine and pathologic features of PPNAD and AIMAHhave been well documented (1) (2) (3) (4) (5) (6) . However, the pathogenesis of bilateral adrenocortical adenomas appears to be heterogeneous (7) (8) (9) (10) (11) (12) (13) .
In the present case, diagnosed as
Cushing's syndrome due to bilateral adenomas, microscopic studies and immunohistochemical studies for steroidogenic enzymes showed marked differences between the right and left tumors.
In the past few years, mutations in G proteins have been identified as the causes of several endocrine diseases (14). G protein genes encoding Gs a and Gi2 were also examined for activating mutations at codons 201 and 227 (Gs a) and codons 179 and 205 (Gi2 a) in the adrenal tumor tissues.
Case Report
A 48-year-old woman was hospitalized because of Cushingoid appearance. For several years, she had been amenorrheal and was being treated for hypertension. She had gained 17 kg over the last 5 years. Dependent edema had been noted for 2 years. The laboratory data were consistent with ACTH-independent Cushing 's syndrome, as described below. The patient's height was 163 cm, and her body weight was 84 kg. The blood pressure was 128/70 mmHgwhile she was on an antihypertensive drug. She had central obesity, moon face, thin skin, easy bruisability, striae cutis, hirsutism and pitting edemaof the lower extremities. There was no cutaneous hyperpigmentation or spotty pigmentation. Radiographs of the chest showed mild cardiomegaly, while those of the thoracic and lumbar vertebrae revealed osteoporosis. The initial laboratory data were as follows. The white blood cell count was 1 1,300 per cubic millimeter with a shift to the left, and 0% eosinophils. In addition, serum potassium was 3.6 mEq//, fasting blood glucose 79 mg/dl, morning serum cortisol 3 1 jag/dl, morning plasma ACTHnot detectable (lower than 5 pg/ml), urinary cortisol 414 jug/day (normal 20-100 (ig/day), serum dehydroepiandrosterone sulfate 626 ng/ml (normal 500-2,500 ng/ml), plasma renin activity 1.1 ng/ml/h, and serum aldosterone 4.2 ng/dl. The results of endocrine studies of the hypothalamic-pituitary-adrenal axis are shown in Table 1 . The diurnal rhythm of serum cortisol was lost. The urinary 17-OHCSdid not respond to the administration of dexamethasone or metyrapone (Table 1) . Administration of 100 jug of human corticotropin-releasing hormone (CRH) did not influence the level of serum cortisol or plasma ACTH(lower than 5 pg/ml). Oral administration of 75 g of glucose also did not influence the serum cortisol level (Table 1) . Computed tomography (CT) scans of the abdomen showed bilateral adrenal tumors ( Fig. 1) , while CTscans of the sella turtica revealed nothing remarkable. An iodocholesterol scintigram showed bilateral adrenal activity (Fig. 2) .
On February 1995, bilateral total adrenalectomy was performed. The right adrenal gland weighed 6.8 g and contained an oval-shapedbrown tumor (3.5 x 2.8 cm) (Fig. 3) . The tumor was encapsulated and consisted mainly of compact cells (Fig. 4A) , while the surrounding cortex was atrophied (Fig. 4B) . The left adrenal gland weighed 5.8 g and contained a round tumor (2.4 x 2.2 cm) (Fig. 3) . The major tumor was encapsulated and composed predominantly of clear cells (Fig. 4C) . The surrounding cortex contained numerous small adrenocortical cell nodules, and intervening adrenocortical tissue was not clearly found ( Fig. 4D ). Microscopic examination confirmed that the bilateral tumors were benign adrenocortical adenomas. Since the bilateral adrenalectomy, the patient has been on dexamethasone (0.5 mg/day) or prednisolone (5 mg/day). The plasma ACTHlevel has been below or only slightly above the limit of detection of the assay (5 pg/ml). "^Dexamethasone was administered orally 1 mg every 6 h on days 2 and 3. *750 mg ofmetyrapone was administered orally every 4 h on day 3. *100 jig of human CRHwas administered intravenously at 0 min. §75 g glucose was administered orally at 0 min. Plasma ACTHwas undetectable by the ACTHassays (lower than 5 pg/ml). was intense in the compact cells of the right adrenocortical adenoma, while it was negative in the adjacent non-neoplastic cortex. Immunoreactivity of all the steroidogeneic enzymes was also detected in the major left adrenal tumor, with marked 3p-HSD and weak P450cl7 immunoreactivity (Figs. 5, 6 ). In the adrenocortical nodules, 3p-HSDimmunoreactivity was sporadically observed (Fig. 5) . Genomic DNAfrom the bilateral tumor tissues obtained at the time of surgery was extracted by standard procedures. DNA was amplified by the polymerase chain reaction (PCR) with 2 sets of primers flanking codons 201 and 227 of the human Gs a geneandcodons 179 and205 ofthehumanGi2 agene (14). The PCRmixture contained 2.5 U Taq DNApolymerase and 30 pmol of each primer. Amplification was accomplished in 30 cycles of 1 minute at 94°C, 2 minutes at 58°C and 3 minutes at 72°C in a Perkin-Elmer Cetus Thermocycler. Amplified DNA was purified and subjected to direct DNAsequence using the Sequenase kit (U.S. Biochemicals, Cleveland, OH). Genomic left adrenal gland harbored one large adenoma which showed different histological features and patterns of expression of steroidogenic enzymes compared to the right adrenal tumor. In addition, numeroussmall adrenocortical nodules expressing steroidogenic enzymesexisted, and the intervening cortical tissues were not found in the left adrenal. It is speculated that, in this patient, the right adrenocortical adenomamight efficiently produce and dominantly secrete cortisol as compared to the left adrenal tumor. These features of bilateral adenomaof our patient are clearly different from tho se des cribed for PPNAD or AIMAH.For instance, in AIMAH,the histological features reveal a combination of cord-forming clear cells and nestforming compact cells (15), and P450cl7 and 3 weaklyexpressed in the clear cells and compactcells, respectively (2) (3) (4) . In PPNAD,the adrenal cortex consists mainly of compact cells with dispersed micronodules which strongly express all steroidogenic enzymes (1) . Bilateral macronodular hyperplasia is found in older patients with long-standing Cushing's disease (16). The nodules compress the surrounding cortex, which is, without exception, hyperplastic. A transition from pituitary-dependent to ACTH independent solitary adrenocortical adenoma has been postulated (17). It is still uncertain whether there is ever progression to true autonomy. Other mechanismshave been proposed for the development of bilateral adrenocortical adenomas or nodular adrenal hyperplasia. An aberrant adrenal sensitivity to gastric inhibitory polypeptide (GIP) underlies Cushing ' s syndrome with nodular adrenal hyperplasia (1 8, 19 ). This does not appear to apply to this case, since the plasma cortisol did not increase in response to oral glucose administration accompanying the increased GIP secretion (18, 19) . G protein mutations occur in a wider range of endocrine conditions than has been recognized hitherto (20) . Activating mutations of the oc-subunits of Gs and Gi2 a that convert these subunits into putative oncogenes have been described in patients with multiple endocrinopathies, including nodular and hyperplasic adrenal glands accompanied by pituitary adenoma (14). However, we could not detect activating mutations at codons 201 and 227 of the Gs a subunit or codons 179 or 205 of the Gi2 a subunit in the tumor tissue from the present case.
